Xiaolin Tang
14Patents
5h-index
15Co-inventors
63Inventor score
Filing activity: Jul 16, 2003 → Jun 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8945559B2 | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies | Chemistry; Metallurgy | 44 | Active |
| US6971187B1 | Automated process control using manometric temperature measurement | Mechanical Engineering; Lighting; Heating | 31 | Expired |
| US9238692B2 | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies | Chemistry; Metallurgy | 22 | Active |
| US10435473B2 | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies | Chemistry; Metallurgy | 13 | Active |
| US10342876B2 | Process for reducing subvisible particles in a pharmaceutical formulation | Human Necessities | 8 | Active |
| US11351256B2 | Room temperature stable lyophilized protein | Emerging Cross-Sectional Technologies | 4 | Active |
| US11525629B2 | Target residual moisture content for lyophilized drug product | Mechanical Engineering; Lighting; Heating | 2 | Active |
| US11241498B2 | Room temperature stable lyophilized protein | Emerging Cross-Sectional Technologies | 1 | Active |
| US11059896B2 | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies | Chemistry; Metallurgy | 1 | Active |
| US11713922B2 | Target residual moisture content for lyophilized drug product | Mechanical Engineering; Lighting; Heating | 1 | Active |
| US11926670B2 | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies | Chemistry; Metallurgy | 0 | Active |
| US12042538B2 | Methods of reducing particle formation and compositions formed thereby | Human Necessities | 0 | Active |
| US12066246B2 | Target residual moisture content for lyophilized drug product | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US12070502B2 | Process for reducing subvisible particles in a pharmaceutical formulation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.